Abstract Adding anti-PD-1 or anti-VEGF therapy to chemotherapy improves survival in patients with advanced gastric cancer, yet outcomes remain poor. This Phase Ib/II trial aimed to evaluate the efficacy and safety of combining sintilimab, the bevacizumab biosimilar IBI305, and CapeOX chemotherapy as a first-line treatment for patients with HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma (GA/GEJA).
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Feng Bi
Adjuvant Chemoradiotherapy or Chemotherapy After D2 Gastrectomy in Gastric Cancer : A Randomized Clinical Trial
|
By Xin Wang, Ouying Yan, Jitao Zhou, Feng Wen, Yali Shen, Zhiping Li, Qiu Li, Wenling Wang, Xiaohong Cai, Shisheng Tan, Zi Wang, Qing Qiao, Dan Cao, Meng Qiu, Jiyan Liu, Hongfeng Gou, Ming Liu Verified, Cheng Yi, Yu Yang, Qing Zhu, Deyun Luo, Yaqin Zhao, Ye Chen, Shang Wang, Qiaoli Wang, Ke Cheng, Min Ren, Xin Chang Liu, Feng Xu, Feng Bi
|
JAMA Network
Verified
Adjuvant Chemoradiotherapy or Chemotherapy After D2 Gastrectomy in Gastric Cancer: A Randomized Clinical Trial Supplement 1. Supplement 2. eTable 1. Multivariable Cox Proportional Hazards Regression Analyses for Disease-Free Survival and Overall Survival eTable 2. All Grade and Maximum Grade Adverse Events eFigure 1. Trial Design and Treatment Schema eFigure 2. Per-Protocol Disease-Free Survival eFigure 3. Per-Protocol Overall Survival eFigure 4. Subgroup Analyses of Overall Survival Supplement 3.
Engineering triple O-Ti-O vacancy associates for efficient water-activation catalysis - Nature Communications
Abstract Defect engineering can create various vacancy configurations in catalysts by finely tuning the local electronic and geometric structures of the active sites. However, achieving precise control and identification of these defects remains a significant challenge, and the origin of vacancy configurations in catalysts, especially clustered or associated ones, remains largely unknown.
Donafenib Versus Sorafenib in First-Line Treatment of Unresectable or Metastatic Hepatocellular Carcinoma: A Randomized, Open-Label, Parallel-Controlled Phase II-III Trial | Journal of Clinical Oncology
Liver cancer is one of the most common cancers worldwide and in China.1,2 China has the highest global incidence, accounting for more than half of the new cases and deaths caused by liver cancer in the world.1,2 Hepatocellular carcinoma (HCC) represents 90% of liver malignancies.3 Most patients are diagnosed at the advanced stage with a median survival of 6-8 months.3 The diagnosis and treatment of HCC is a major public health concern in China.4 CONTEXT Key Objective Sorafenib is a standard...
Synergistic Elimination of NOx and Chloroaromatics on a Commercial V2O5-WO3/TiO2 Catalyst: Byproduct Analyses and the SO2 Effect
The synergistic control of multipollutants is the frontier of environmental catalysis. This research is in the infancy stage, and many uncertainties still remain. Herein, we investigated the reaction characteristics of synergistic elimination of NOx and chloroaromatics on a commercial V2O5–WO3/TiO2 catalyst. The reaction byproducts were qualitatively and quantitatively analyzed, and their origins were clarified.
Thermocatalytic Syntheses of Highly Defective Hybrid Nano-catalysts for Photocatalytic Hydrogen Evolution
Defects play important roles in many catalytic processes, particularly for photocatalytic processes in semiconductors as they can alter band structures and affect excited electron-hole recombination pathways/lifetimes of semiconductors. In this report, we described the development of a facile route to the production of highly defective photocatalysts.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Feng
Contact Feng, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack